OTC:SHWZ

Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET

Retrieved on: 
Monday, April 29, 2024
OTCQX, Interest, Medicine

DENVER, April 29, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, May 15, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the first quarter ended March 31, 2024.

Key Points: 
  • DENVER, April 29, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, May 15, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the first quarter ended March 31, 2024.
  • The Company's results will be reported in a press release prior to the call.
  • The Schwazze management team will host the conference call, followed by a question-and-answer period.
  • Interested parties may submit questions to the Company prior to the call by emailing [email protected] .

Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET

Retrieved on: 
Monday, April 29, 2024
OTCQX, Interest, Medicine

DENVER, April 29, 2024 /PRNewswire/ -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, May 15, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the first quarter ended March 31, 2024.

Key Points: 
  • DENVER, April 29, 2024 /PRNewswire/ -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, May 15, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the first quarter ended March 31, 2024.
  • The Company's results will be reported in a press release prior to the call.
  • The Schwazze management team will host the conference call, followed by a question-and-answer period.
  • Interested parties may submit questions to the Company prior to the call by emailing [email protected] .

Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Wednesday, March 27, 2024
Tax, Pressure, Interest, Growth, Acquisition, Depreciation, Fort Collins, Colorado

Total revenue in the fourth quarter of 2023 increased 8% to $43.3 million compared to $40.1 million for the same quarter last year.

Key Points: 
  • Total revenue in the fourth quarter of 2023 increased 8% to $43.3 million compared to $40.1 million for the same quarter last year.
  • Operating expenses for the fourth quarter of 2023 were $23.3 million compared to $24.2 million for the same quarter last year.
  • Loss from operations for the fourth quarter of 2023 was $16.2 million compared to $2.5 million in the same quarter last year.
  • Net loss was $33.9 million for the fourth quarter of 2023 compared to $27.3 million for the same quarter last year.

Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Wednesday, March 27, 2024
Tax, Pressure, Interest, Growth, Acquisition, Depreciation, Fort Collins, Colorado

DENVER, March 27, 2024 /PRNewswire/ -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe: SHWZ) ("Schwazze" or the "Company"), today announced financial and operational results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • Total revenue in the fourth quarter of 2023 increased 8% to $43.3 million compared to $40.1 million for the same quarter last year.
  • Operating expenses for the fourth quarter of 2023 were $23.3 million compared to $24.2 million for the same quarter last year.
  • Loss from operations for the fourth quarter of 2023 was $16.2 million compared to $2.5 million in the same quarter last year.
  • Net loss was $33.9 million for the fourth quarter of 2023 compared to $27.3 million for the same quarter last year.

Schwazze Sets Fourth Quarter and Full Year 2023 Conference Call for March 27, 2024 at 5:00 p.m. ET

Retrieved on: 
Tuesday, March 12, 2024
Medicine, Interest, OTCQX

DENVER, March 12, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, March 27, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • DENVER, March 12, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, March 27, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the fourth quarter and full year ended December 31, 2023.
  • The Company's results will be reported in a press release prior to the call.
  • The Schwazze management team will host the conference call, followed by a question-and-answer period.
  • Interested parties may submit questions to the Company prior to the call by emailing [email protected] .

Schwazze Sets Fourth Quarter and Full Year 2023 Conference Call for March 27, 2024 at 5:00 p.m. ET

Retrieved on: 
Tuesday, March 12, 2024
Medicine, Interest, OTCQX

DENVER, March 12, 2024 /PRNewswire/ -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, March 27, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • DENVER, March 12, 2024 /PRNewswire/ -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, March 27, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the fourth quarter and full year ended December 31, 2023.
  • The Company's results will be reported in a press release prior to the call.
  • The Schwazze management team will host the conference call, followed by a question-and-answer period.
  • Interested parties may submit questions to the Company prior to the call by emailing [email protected] .

Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer

Retrieved on: 
Friday, February 23, 2024
New Seasons Market, Whole Foods Market, OTCQX, NEO, Medicine, Adjustment

DENVER, Feb. 23, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the "Company"), today announced that Forrest Hoffmaster, the Company's Chief Financial Officer, has been appointed to the additional role of interim Chief Executive Officer ("CEO").

Key Points: 
  • DENVER, Feb. 23, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the "Company"), today announced that Forrest Hoffmaster, the Company's Chief Financial Officer, has been appointed to the additional role of interim Chief Executive Officer ("CEO").
  • This follows Nirup Krishnamurthy's resignation as CEO and as a member of the Board of Directors ("Board"), effective February 20, 2024, due to personal reasons.
  • Mr. Hoffmaster, who joined the Company in January 2023, brings over 30 years of executive experience in finance and operations for both public and private companies.
  • Prior to New Seasons Market, Forrest held leadership positions with other leading grocers including Whole Foods Market and H-E-B.

Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer

Retrieved on: 
Friday, February 23, 2024
New Seasons Market, Whole Foods Market, OTCQX, NEO, Medicine, Adjustment

DENVER, Feb. 23, 2024 /PRNewswire/ -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the "Company"), today announced that Forrest Hoffmaster, the Company's Chief Financial Officer, has been appointed to the additional role of interim Chief Executive Officer ("CEO").

Key Points: 
  • DENVER, Feb. 23, 2024 /PRNewswire/ -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the "Company"), today announced that Forrest Hoffmaster, the Company's Chief Financial Officer, has been appointed to the additional role of interim Chief Executive Officer ("CEO").
  • This follows Nirup Krishnamurthy's resignation as CEO and as a member of the Board of Directors ("Board"), effective February 20, 2024, due to personal reasons.
  • Mr. Hoffmaster, who joined the Company in January 2023, brings over 30 years of executive experience in finance and operations for both public and private companies.
  • Prior to New Seasons Market, Forrest held leadership positions with other leading grocers including Whole Foods Market and H-E-B.

Schwazze Announces Third Quarter 2023 Financial Results

Retrieved on: 
Tuesday, November 14, 2023
EBITDA, Interest, Pressure, Acquisition, Tax, Depreciation, Patient, Fort Collins, Colorado, Farm, ERP, Growth, Drug, Retail, Hospital, Video game, Q3

Third quarter ecommerce transactions in New Mexico and Colorado increased a collective 28% compared to the second quarter of 2023.

Key Points: 
  • Third quarter ecommerce transactions in New Mexico and Colorado increased a collective 28% compared to the second quarter of 2023.
  • Operating expenses for the third quarter of 2023 were $12.5 million compared to $11.4 million for the same quarter last year.
  • Income from operations for the third quarter of 2023 was $8.9 million compared to $11.1 million in the same quarter last year.
  • The Company will conduct a conference call today, November 14, 2023, at 5:00 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2023.

Schwazze Announces Third Quarter 2023 Financial Results

Retrieved on: 
Tuesday, November 14, 2023
EBITDA, Interest, Pressure, Acquisition, Tax, Depreciation, Patient, Fort Collins, Colorado, Farm, ERP, Growth, Drug, Retail, Hospital, Video game, Q3

DENVER, Nov. 14, 2023 /PRNewswire/ -- Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (NEO: SHWZ) ("Schwazze" or the "Company"), today announced financial and operational results for the third quarter ended September 30, 2023.

Key Points: 
  • Third quarter ecommerce transactions in New Mexico and Colorado increased a collective 28% compared to the second quarter of 2023.
  • Operating expenses for the third quarter of 2023 were $12.5 million compared to $11.4 million for the same quarter last year.
  • Income from operations for the third quarter of 2023 was $8.9 million compared to $11.1 million in the same quarter last year.
  • The Company will conduct a conference call today, November 14, 2023, at 5:00 p.m. Eastern time to discuss its results for the third quarter ended September 30, 2023.